Despite the role of IL-35 in suppressing inflammatory diseases and inhibiting cytotoxic CD8+ anti-tumor T cells that prevent tumor metastasis (47, 61, 64), gaps in mechanistic understanding of how IL-35 mediates immunosuppression have prevented its therapeutic use. Here, CD8A is linked to neoplasm.